when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

ROCHE · news · pharmadog

← back to ROCHE

News mentioning ROCHE

262 stories

Sep 1, 26Roche inks $1.53B deal for Simcere’s B-cell-targeting antibodyfiercebiotech

Sep 1, 26ArsenalBio sheds most of staff in pivot to in vivo CAR-Tfiercebiotech

Aug 31, 26ESC: Alnylam's next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CMfiercebiotech

Aug 31, 26BMS’ neuro renaissance was built on back of Celgene mega-mergerbiospace

Aug 28, 26BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancerbiospace

Aug 28, 26Genentech strikes second Asia deal in a week, betting up to $1B in oncology ADC alliance with DualityBiobiospace

Aug 28, 26Roche bets $1B+ on DualityBio's ADC tech to tackle TOPO1 resistanceendpoints

Aug 28, 26Why Roche is 'really excited' about a UCN2 analog for obesity after seeing preclinical datafiercebiotech

Aug 28, 26Genentech doubles down on ADC-resistant cancers with $1B DualityBio pactfiercebiotech

Aug 27, 26Chutes & Ladders—Vivace revs up C-suite ahead of pivotal pushfiercebiotech

Aug 27, 26Myriad catalysts on deck for obesity’s brightest stars as market continues to acceleratebiospace

Aug 27, 26Roche nabs expanded FDA approval for diagnostic tied to Jazz’s cancer drugfiercebiotech

Aug 26, 26Spyre tumbles as immune drug misses mark in rheumatoid arthritisbiopharma dive

Aug 26, 26STAT+: Pharmalittle: We’re reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and morestat

Aug 26, 26Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debatefiercebiotech

Aug 26, 26Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’ in biopharma racefiercebiotech

Aug 26, 26Spyre’s rheumatoid arthritis plan toppled by subpar TL1A datafiercebiotech

Aug 25, 26New Jazz cancer drug approval could drive blockbuster salesbiopharma dive

Aug 25, 26Roche, Eli Lilly get FDA nod for new Alzheimer’s blood testbiopharma dive

Aug 25, 26STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugsstat

Aug 25, 26STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and morestat

Aug 25, 26Labcorp launches new hepatitis D test to find patients with most severe form of virusfiercebiotech

Aug 24, 26Roche commits to lean-mass preservation with Hanmi obesity dealbiopharma dive

Aug 24, 26STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and morestat

Aug 24, 26Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drugbiospace

Aug 24, 26Roche bets up to $2.3B on Hanmi’s early-stage muscle-building obesity assetendpoints

Aug 24, 26TME holds onto $1B dream for brain cancer drug as search for partners nears conclusionfiercebiotech

Aug 24, 26Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood testfiercebiotech

Aug 24, 26Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanismfiercebiotech

Aug 24, 26Recon: FDA clears Roche, Lilly Alzheimer’s blood tests; Regenxbio gene therapy trial halted by FDA againraps

← prevpage 5 of 9next →